Skip to main content


Company Information

Company Profile

Cidara Therapeutics is using its proprietary Cloudbreak® platform to develop novel drug-Fc conjugates (DFCs). These targeted immunotherapies offer the unique opportunity to create “single molecule cocktails” comprised of targeted small molecules and peptides coupled to a human antibody fragment (Fc). DFCs are designed to save lives and improve the standard of care for patients facing serious diseases by inhibiting specific disease targets while simultaneously engaging the immune system. Cidara is headquartered in San Diego, California.

IR Contacts

Cidara Contact
6310 Nancy Ridge Drive, Suite 101
San Diego, CA 92121
(858) 752-6170

Investor Contact
Brian Ritchie
LifeSci Advisors
(212) 915-2578

Media Contact
Michael Fitzhugh
LifeSci Communications

Transfer Agent
Equiniti Trust Company (formerly AST)
48 Wall Street, 22nd Floor
New York, NY 10005
(877) 248-6417 or (718) 921-8317

Whistleblower Hotline
Leave a Confidential Message
(866) 760-2381

Frequently Asked Questions

When was Cidara founded?

Cidara was founded in 2012.

Where is Cidara incorporated?

Cidara was incorporated in Delaware in December 2012 as K2 Therapeutics, Inc. and its name was changed to Cidara Therapeutics, Inc. in July 2014.

Where is Cidara's corporate headquarters?

6310 Nancy Ridge Drive, Suite 101
San Diego, CA 92121
(858) 752-6170

Who are the members of Cidara's Board of Directors?

You can view our Board of Directors by visiting the “Board of Directors” section of our website.

Who are the members of Cidara's management team?

You can view our management team by visiting the “Management Team” section of our website.

On which exchange is Cidara listed and what is the ticker symbol?

Cidara is traded on The NASDAQ Global Market under the symbol “CDTX.”

When did Cidara go public?

Cidara went public on April 15, 2015.

How can I purchase shares?

Shares can be purchased through a stockbroker of your choice.

Does Cidara have a direct stock purchase plan?

Cidara does not currently offer a direct stock purchase plan.

Does Cidara pay dividends and have a dividend reinvestment program?

Currently, Cidara does not offer a dividend or a dividend reinvestment program

Who is Cidara's transfer agent and how do I contact them?

Cidara’s transfer agent is Equiniti Trust Company (formerly AST). You can find more information about how to contact Equiniti Trust Company at:

Equiniti Trust Company (formerly AST)
(877) 248-6417 or (718) 921-8317
48 Wall Street, 22nd Floor
New York, NY 10005

How can I replace my lost stock certificates?

Please contact our transfer agent Equiniti Trust Company (formerly AST) at or by phone at (877) 248-6417 or (718) 921-8317. Our Transfer Agent can look up your records and make any necessary adjustments. There is a fee involved for replacing lost certificates.

How do I report a change of mailing address?

You must send both your old and new addresses to our transfer agent,, by phone at (877) 248-6417 or (718) 921-8317, or by mail. Each stockholder in question must sign the request for an address change.

How can I get a copy of your Annual Report or any other investor materials such as an Investor Relations kit or 10-K?

Quarterly & Annual Reports and other investor materials, when available, can be found in the “SEC Filings” section of our corporate website. Additionally, all SEC filings can be accessed directly from the SEC at

Where can I find recent Cidara press releases?

You can view our recent press releases by visiting the “Press Releases” section of our website.

Where can I find more information on Cidara's R&D programs?

You can view information on our development programs by visiting the “Pipeline” section of our website.

How do I contact Investor Relations with a question or request?

For investor related media inquiries, please send an email to For all other media related inquiries, please send an email to